ENT

Your Article Summary

See Latest Articles

Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy
International Journal of Radiation Biology, 09/04/09

Hentschel M et al. – Data suggest that a reduction of treatment volume is not possible by an adaptive re–planning based on FDG–PET, e.g., at 50 Gy. This may be caused by a consecutive therapy associated inflammation. This limitation is probably related to the use of a source–to–background based algorithm.

Today in Head and Neck...keeping you current

Receive free subspecialty "5-minute updates" via email

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09

Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
Thyroid, 11/02/09

See All of Head and Neck

Today in Radiology/Diagnostics...keeping you current

Receive free subspecialty "5-minute updates" via email

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09

Nystagmus during Attacks of Vestibular Migraine: An Aid in Diagnosis
Audiology & Neuro-Otology, 11/05/09

Prognostic value of 18F-FDG PET/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma
Annals of Oncology, 11/19/09

See All of Radiology/Diagnostics